{"disease":{"id":"colon-adenocarcinoma","name":"colon adenocarcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05080673","title":"Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps","phase":"NA","overall_status":"RECRUITING","enrollment_count":9500,"lead_sponsor_name":"NRG Oncology","has_results":false},{"nct_id":"NCT07167147","title":"Survival Outcomes by Tumor-Node Stage and Recurrence Patterns in Colon Cancer After Radical Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":7259,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT07143487","title":"Family Communications After Genetic Testing","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":4186,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT00096278","title":"Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2710,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06864338","title":"Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test","phase":"","overall_status":"RECRUITING","enrollment_count":2700,"lead_sponsor_name":"Mainz Biomed","has_results":false},{"nct_id":"NCT00217737","title":"Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2431,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT06216405","title":"Performance of Artificial Intelligence in Colonoscopy for Right Colon Polyp Detection","phase":"NA","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Groupe Hospitalier Diaconesses Croix Saint-Simon","has_results":false},{"nct_id":"NCT06971107","title":"Current Microsatellite Stability Results in Colon Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Turkish Society of Colon and Rectal Surgery","has_results":false},{"nct_id":"NCT06050447","title":"Factors Affecting the Results of Treatment of Patients With Colorectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Immanuel Kant Baltic Federal University","has_results":false},{"nct_id":"NCT03896958","title":"The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"SpeciCare","has_results":false},{"nct_id":"NCT04441580","title":"Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in a Screening Setting","phase":"NA","overall_status":"COMPLETED","enrollment_count":900,"lead_sponsor_name":"Fondazione Poliambulanza Istituto Ospedaliero","has_results":false},{"nct_id":"NCT02863107","title":"Young-Onset Colorectal Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05038254","title":"Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":750,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT02912559","title":"Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":712,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04068103","title":"Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":635,"lead_sponsor_name":"NRG Oncology","has_results":true},{"nct_id":"NCT03037385","title":"Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":590,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT06997497","title":"A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":477,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03506321","title":"Comparison of the Benefit of Chromoendoscopy in Addition to High Definition White Light and Narrow Band Imaging for the Prediction of Submucosal Invasive Cancer in Colonic Lesions","phase":"NA","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Western Sydney Local Health District","has_results":false},{"nct_id":"NCT06652672","title":"Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":341,"lead_sponsor_name":"Meander Medical Center","has_results":false},{"nct_id":"NCT04526314","title":"Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older","phase":"","overall_status":"COMPLETED","enrollment_count":308,"lead_sponsor_name":"Registre des Tumeurs Digestives du Finistère","has_results":false},{"nct_id":"NCT03365882","title":"S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":true},{"nct_id":"NCT06682793","title":"A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"A2 Biotherapeutics Inc.","has_results":false},{"nct_id":"NCT03765736","title":"Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial","phase":"","overall_status":"TERMINATED","enrollment_count":199,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":true},{"nct_id":"NCT04349384","title":"Audit of Surgery for Colorectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":136,"lead_sponsor_name":"Institut National d'Oncologie, Morocco","has_results":false},{"nct_id":"NCT07358585","title":"A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":126,"lead_sponsor_name":"Shanghai Henlius Biotech","has_results":false},{"nct_id":"NCT02368886","title":"Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":true},{"nct_id":"NCT05872334","title":"The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT07468630","title":"Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":106,"lead_sponsor_name":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","has_results":false},{"nct_id":"NCT06709885","title":"HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","has_results":false},{"nct_id":"NCT03015038","title":"Study of the Immune Response in Colon Adenocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT05422547","title":"Role of Immunoscore® in Stage II-III Colorectal Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"D'Or Institute for Research and Education","has_results":false},{"nct_id":"NCT05080088","title":"Retrospective Evaluation of 3 Colonic Adenoma Detection Strategies","phase":"","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT05308446","title":"Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":84,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04668872","title":"Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT06017141","title":"Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"University of Kansas Medical Center","has_results":false},{"nct_id":"NCT03949777","title":"Validation of Aer-O-Scope Colonoscope System Cecal Intubation","phase":"NA","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"GI View Ltd.","has_results":false},{"nct_id":"NCT03803891","title":"Endoscopic Full-Thickness Resection In Colon","phase":"","overall_status":"UNKNOWN","enrollment_count":65,"lead_sponsor_name":"Fundació Institut Germans Trias i Pujol","has_results":false},{"nct_id":"NCT04003181","title":"The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon","phase":"NA","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06426927","title":"PeLear CCC: Proyecto Latino Contra Cancer Colorrectal","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":true},{"nct_id":"NCT01652196","title":"Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"John Hays","has_results":true},{"nct_id":"NCT03871959","title":"Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT04599140","title":"SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":51,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06840977","title":"COLON ERDERLY LOW DOSE","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":51,"lead_sponsor_name":"Matteo Clavarezza","has_results":false},{"nct_id":"NCT04704661","title":"Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":51,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03871790","title":"Peptide-based Immunization for Colon- and and Pancreas-carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false},{"nct_id":"NCT04624555","title":"The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT04475159","title":"Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Prof. Aviram Nissan","has_results":false},{"nct_id":"NCT04005118","title":"Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03415126","title":"A Study of ASN007 in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Asana BioSciences","has_results":false},{"nct_id":"NCT03602079","title":"Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Klus Pharma Inc.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}